ATOPIC DERMATITIS CME COURSES
Atopic dermatitis (AD) has long been recognized as a common, chronic inflammatory skin disease. However, an expanding body of scientific evidence, coupled with a deeper understanding of the immunopathologic mechanisms underscoring AD development, suggest that it should be recognized and treated as a systemic disorder. Evidence implies the involvement of systemic immunologic activation in the modification of the skin barrier, consequentially affecting non-lesioned skin in a subclinical, histologically distinct manner. Because of the common misconception that AD is a limited, site-specific skin disease, patients are often mistreated with excessive corticosteroids, multiple confusing topical treatment regimens, or undertreated altogether. Additionally, recent advances in the systemic management of AD have added a new level of complexity to the clinical scene.
The CME-accredited educational curricula provided here by RMEI Medical Education, LLC are designed to engage practicing clinicians with actionable insights for improving the delivery of patient care. Some of the world’s foremost clinical experts on atopic dermatitis are featured as faculty, in video and audio dialogues, with real patients. New activities and live meetings are added regularly, so be sure to check back for updates!